Share on LinkedInShare on LinkedIn

ARTICLE · 01 JUNE 2026

Transfer Pricing Rules In Canada

Bennett Jones LLP
Bennett Jones LLP
Contributor
Bennett Jones LLP

Bennett Jones LLP

Bennett Jones is one of Canada’s premier business law firms. With deep experience in complex...

View firm profile
Explore more from Bennett Jones LLP

On March 26, 2026, Canada's new transfer pricing rules received royal assent and will have a significant impact on multi-national enterprises (MNEs) in life sciences industries.

CanadaTax

On March 26, 2026, Canada's new transfer pricing rules received royal assent and will have a significant impact on multi-national enterprises (MNEs) in life sciences industries. The rules now focus on enumerated "economically relevant characteristics" which will affect how the Canada Revenue Agency scrutinizes cross-border transactions. For life sciences companies operating cross-border, proactive compliance and assessment of transfer pricing considerations is essential to ensure that the CRA does not inappropriately challenge the chosen transfer price of MNE intra-group transactions.

Key Takeaways

Life science companies that operate across borders should be aware of the following:

  • The rules can affect how an MNE carries on business and, possibly, its ability to carry on business in certain jurisdictions. MNEs must give proper attention to the relationship between two (or more) members of the MNE to avoid the MNE being subjected to the taxation of the same income in more than

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from